CMA may aid cancer proliferation by the degradation of the inhibitors of cell proliferation, such as Rho-related GTP binding protein RhoE (RND3] [122], and pro-apoptotic protein Bcl-2-binding component 3 (BBC3) [123]. The gene discussed is BBC3; the disease is cancer.